2020
DOI: 10.1016/j.virol.2020.03.006
|View full text |Cite
|
Sign up to set email alerts
|

An RNA-dependent RNA polymerase inhibitor for tick-borne encephalitis virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 39 publications
0
5
0
Order By: Relevance
“…However, these observations concern immune cells, which reflection in the plasma or CSF has not been described in the literature yet. A natural reduction in ATP synthesis and hydrolysis in nerve cells in response to TBE could significantly limit viral replication 46 . Therefore, it is not clear, whether the observed decreased level of mentioned proteins in CSF of TBE patients may be correlated with the metabolism of immune cells, or it depends on other factors caused indirectly by the virus or connected with body's defense response.…”
Section: Discussionmentioning
confidence: 99%
“…However, these observations concern immune cells, which reflection in the plasma or CSF has not been described in the literature yet. A natural reduction in ATP synthesis and hydrolysis in nerve cells in response to TBE could significantly limit viral replication 46 . Therefore, it is not clear, whether the observed decreased level of mentioned proteins in CSF of TBE patients may be correlated with the metabolism of immune cells, or it depends on other factors caused indirectly by the virus or connected with body's defense response.…”
Section: Discussionmentioning
confidence: 99%
“…While the lack of flavivirus RdRp structures in their catalytically competent state represents a challenge for structure-based drug discovery approaches, a recent structure of TBEV RdRp helped to identify the differences in catalytic sites between tick-borne and mosquito-borne flaviviruses. These differences were shown to be vital in host recognition, expanding the known RdRp roles in the infection cycle [45,57].…”
Section: Drug-repurposing and Computational Structure-based Drug Designmentioning
confidence: 99%
“…Enhanced Ligand Exploration and Interaction Recognition Algorithm (ELIXIR-A) [38][39][40][41] (ELIXIR-A) was used for isolating pharmacophore points based on the analyses of interactions between VP35 and probe molecules. ELIXIR-A is an in-house pharmacophore screening algorithm that recognizes pharmacophoric features, i.e., the ensemble of steric, electrostatic, and hydrophobic properties that are crucial for optimum supramolecular interactions with the target receptor to inhibit its biological activity.…”
Section: Pharmacophore Identificationmentioning
confidence: 99%